Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. Vir Biotechnology
VIR

Buy Vir Biotechnology (VIR) Stock

VIR
See VIR stock price and Buy/Sell Vir Biotechnology with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
VIR

Vir Biotechnology (VIR)

About Vir Biotechnology (VIR)

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune...Read more
Market Cap
$2.43B
1 Year High
$58
Volume
943.68k
1 Year Low
$18.05
Price to Earnings Ratio
2.28
Open
$18.65
Dividend Rate
High
$18.99
Dividend Yield
Low
$18.51

Community

People who own or watch VIR stock

Vir Biotechnology Price Targets

What analysts think VIR stock price will be.
$18.75
$46.78
149.5% Upside
$17$61

Vir Biotechnology Stock Rating

What analysts recommend for VIR stock, on a scale from 1(buy) to 5(sell).
Buy2.1 / 5
BuyHoldSell

Vir Biotechnology Stock Earnings

The value each VIR share was expected to gain vs. the value that each VIR share actually gained.
Expected
Actual

Vir Biotechnology Stock News

Frequently Asked Questions (FAQ)

As of Sep 27, 2022, the market cap for VIR stock is $2.43B

The current P/E ratio for VIR stock is 2.28

The 52-week high for VIR stock is $58. The current VIR stock price $18.75 is 67.67% below its 52-week high

The 52-week low for VIR stock is $18.05. The current VIR stock price $18.75 has increased 3.73% from its 52-week low

No, the VIR stock does not pay dividends to its shareholders

The target price for VIR stock is $46.78 based on the average of what a group of analyst think VIR stock could be worth at a future date. This is not a prediction by Public.com

Buy Vir Biotechnology (VIR) Stock

VIR
See VIR stock price and Buy/Sell Vir Biotechnology with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch VIR stock
  • dreadygirl2126 avatar
  • jsussman721 avatar
  • amandafaulknermedia avatar
  • wingz avatar
  • chelseamckay avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.